"Showdown in Luxembourg" over pharmacy ownership laws

20 July 2008

With the European Court of Justice set to review German and Italian pharmacy laws on September 3, the restrictions on ownership and establishment of several European Union member states are being challenged. The European Commission has launched proceedings against Austria, Bulgaria, France, Germany, Italy, Portugal and Spain.

Governments throughout Europe are taking steps to defend themselves against the Commission's course of action. Among the issues at stake in the fight about pharmacies in Brussels and Luxembourg, is the central question of whether responsibility for public health is to be determined at national or at European level.

To help in the better understanding of the situation, a new Apotheke AdHoc dossier, "Showdown in Luxembourg," will be released on July 28 in English and is based on research performed across Europe. The 28-page dossier will provide exclusive details on the individual proceedings: interviews, critical analyses of the statements and reports submitted by the various parties. It will answer the questions of who are the people largely were behind the initiation of the proceedings in the various countries, and their aims. For more, visit: www.pharma-adhoc.com.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight